Antisolvent Crystallization of Sulfa Drugs and the Effect of Process Parameters

Abstract Three sulfa drugs (sulfathiazole, sulfamethizole, and sulfabenzamide) were crystallized using carbon dioxide and water as antisolvents, and the effects of the type of solvent, the crystallization temperature, and the antisolvent injection rate were investigated. Sulfathiazole crystallized in granulate form from acetone, but it was crystallized in acicular form from methanol. Sulfamethizole was crystallized in tabulate form from acetone and as plates from DMF. Sulfabenzamide was precipitated in the form of prisms from acetone and of aciculates from ethyl acetate. As the crystallization temperature increased from 30 to 50°C, the average particle size increased from 6.5 to 10.5 µm for sulfathiazole, 29.5 to 53.1 µm for sulfamethizole, and 33.0 to 59.8 µm for sulfabenzamide. The crystal habit tended to become more needle‐like as the antisolvent injection rate increased. Larger particles were produced when the antisolvent was changed from carbon dioxide to water.